Retatrutide 40MG

Retatrutide (GLP-1/GIP/Glucagon Triple Agonist) — 40MG

Sterling Prime Peptides’ Retatrutide 40MG is supplied as a high-purity lyophilised peptide for laboratory and scientific research. Each vial is manufactured to stringent quality standards to provide researchers with a consistent material for investigational applications.

Available as individual vials or as a bundle of 10 vials, allowing researchers to select the quantity best suited to their project requirements.

Specification

• 40MG Retatrutide per vial
• Lyophilised powder
• ≥98% purity
• Available as a single vial or bundle of 10
• For research use only

Supplied with full batch documentation.

Each product undergoes independent third-party testing, with Certificates of Analysis (COAs) available for quality assurance and batch verification.

For research use only. Not intended for human consumption, therapeutic, diagnostic, or clinical use.